International Psoriasis Council

International Psoriasis Council
subscribe
5   What's New
Search
International Psoriasis Council
subscribe
Search

Advancing Knowledge. Improving Care.

Banner for the SID 2026 Annual Meeting in Chicago, Illinois, featuring the SID and IPC logos alongside a black-and-white photo of Chicago skyscrapers reflected in the Cloud Gate (Bean) sculpture.

The Arc of Disease Control in Psoriasis: Early Interception – Deep Pathway Blockade – Treatment Failure

2026 SOCIETY FOR INVESTIGATIVE DERMATOLOGY (SID) | CHICAGO, ILLINOIS, UNITED STATES

May 13, 2026
 |  08:00-11:30 CST
Location: Hilton Chicago | Room: Continental B, Lobby Level

Add event to calendar
Apple   Google   Outlook   Outlook.com   Office 365   Yahoo

Agenda

Welcome and Introduction
Johann Gudjonsson, MD, PhD, United States

Intercepting Psoriasis at the Earliest Stages: Lessons from STEP-IN and GUIDE
Knut Schäkel, MD, Germany

Preventing Psoriatic Arthritis: Can Immune Interception Change the Natural Disease Course?
Shikha Singla, MD, United States

Implications of Controlling Psoriasis Inflammation: From Molecular Profiling to Comorbidities
Alex Tsoi, MS, PhD, United States

Oral Versus Biologics – Targeted or Broader Approaches?
Christopher Bunick, MD, PhD, United States

BREAK

Why Treatment Fails: Interferons, Immune Rewiring, and Biological Escape Mechanisms
Curdin Conrad, MD, Switzerland

Clinical Escape in Psoriasis: Paradoxical Reactions and Flip-Flop Phenomena
Wilson Liao, MD, United States

Case Presentations

Closing Comments
Curdin Conrad, MD, Switzerland

Program Chair

Curdin Conrad, MD

University Hospital of Lausanne

Lausanne, Switzerland

IPC Board Member

Bio

Johann Gudjonsson, MD, PhD

University of Michigan, Department of Dermatology

Ann Arbor, Michigan, United States

IPC Board Member

Bio

Program Faculty

Christopher Bunick, MD, PhD

Yale University

New Haven, Connecticut, United States

IPC Councilor

Bio

Wilson Liao, MD

University of California San Francisco

San Francisco, California, United States

IPC Councilor

Bio

Knut Schäkel, MD

Heidelberg University Hospital

Heidelberg, Germany

Bio

Shikha Singla, MD

Medical College of Wisconsin

Milwaukee, Wisconsin, United States

Bio

Alex Tsoi, MS, PhD

University of Michigan

Ann Arbor, Michigan, United States

IPC Councilor

Bio

This symposium is supported in part by:

What's New

First-Line Biologics in Psoriasis: Evidence from the BADBIR Cohort Study

In this IPC commentary, Matias Maskin examines evidence from the BADBIR registry demonstrating that first-line biologic therapy in moderate to severe psoriasis leads to faster skin clearance, improved quality of life, and a lower risk of comorbidities. The analysis challenges traditional step-up approaches and supports earlier, patient-centered treatment strategies.

Read More »
Monday, April 27, 2026

Recent Advances in Psoriasis: A Year in Review

In this Take Ten with IPC video, Dr. Leandro Leite discusses the most recent advances in psoriasis over the last year (March 2025 – March 2026). Topics include new guidelines, research, and recent studies.

WATCH NOW

Monday, April 6, 2026